Merck to seek authorisation for oral Covid drug

WASHINGTON: Pharmaceutical company Merck said Friday it will seek authorisation in the US for an oral drug for Covid-19, after the pill showed “compelling results” in a clinical trial.

© New Straits Times Press (M) Bhd